GAROFOLO, MONIA
 Distribuzione geografica
Continente #
NA - Nord America 3.075
AS - Asia 1.669
EU - Europa 1.080
SA - Sud America 301
AF - Africa 111
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.239
Nazione #
US - Stati Uniti d'America 2.984
SG - Singapore 599
CN - Cina 418
IT - Italia 351
HK - Hong Kong 275
BR - Brasile 252
VN - Vietnam 144
SE - Svezia 136
DE - Germania 112
GB - Regno Unito 112
FR - Francia 71
BG - Bulgaria 67
CA - Canada 60
RU - Federazione Russa 56
AT - Austria 51
IN - India 41
CI - Costa d'Avorio 33
FI - Finlandia 30
JP - Giappone 30
TR - Turchia 27
NG - Nigeria 24
IQ - Iraq 22
BD - Bangladesh 20
NL - Olanda 20
PL - Polonia 18
MX - Messico 17
IR - Iran 15
AR - Argentina 14
SN - Senegal 14
CH - Svizzera 11
EC - Ecuador 11
EG - Egitto 11
SA - Arabia Saudita 10
ES - Italia 9
PK - Pakistan 9
ZA - Sudafrica 9
ID - Indonesia 8
KR - Corea 8
MY - Malesia 8
UA - Ucraina 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
CO - Colombia 6
KE - Kenya 6
MA - Marocco 6
AZ - Azerbaigian 5
BE - Belgio 5
PH - Filippine 5
UZ - Uzbekistan 5
JM - Giamaica 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
KZ - Kazakistan 3
LT - Lituania 3
PT - Portogallo 3
RS - Serbia 3
TN - Tunisia 3
AO - Angola 2
HN - Honduras 2
IE - Irlanda 2
JO - Giordania 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
QA - Qatar 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
ML - Mali 1
NZ - Nuova Zelanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.239
Città #
Dallas 539
Singapore 328
Ashburn 322
Hong Kong 271
San Jose 209
Santa Clara 191
Chandler 169
Houston 169
Fairfield 163
Woodbridge 119
Shanghai 101
Beijing 87
Milan 85
New York 80
Seattle 71
Sofia 66
Boardman 65
Los Angeles 54
Ann Arbor 52
Wilmington 51
London 48
Ho Chi Minh City 40
Vienna 39
Ottawa 38
Cambridge 37
Princeton 35
Serra 34
Abidjan 33
Munich 31
Frankfurt am Main 30
Manchester 29
Tokyo 29
Chicago 28
Hanoi 28
Lawrence 28
São Paulo 26
Lauterbourg 25
Florence 24
Lagos 24
Hefei 23
Pisa 22
Bremen 21
Cascina 21
Des Moines 21
Turku 21
Medford 20
Redondo Beach 19
Dearborn 17
Chennai 15
Dakar 14
Buffalo 13
Warsaw 12
Council Bluffs 11
Marseille 11
San Diego 11
San Francisco 11
Vicopisano 11
Baghdad 10
Baltimore 10
Dong Ket 10
Kunming 10
Montreal 10
Nanjing 10
Ogden 9
Orem 9
Redwood City 9
Boston 8
Brasília 8
Fuzhou 8
Istanbul 8
Nuremberg 8
Rome 8
Seoul 8
Brno 7
Da Nang 7
Düsseldorf 7
Helsinki 7
Isfahan 7
Rio de Janeiro 7
Amsterdam 6
Ankara 6
Guangzhou 6
Lucca 6
Mexico City 6
Shenyang 6
Wuhan 6
Zurich 6
Atlanta 5
Baku 5
Belo Horizonte 5
Brussels 5
Charlotte 5
Denver 5
Johannesburg 5
Lancaster 5
Porto Alegre 5
Quito 5
Tashkent 5
Toronto 5
Basra 4
Totale 4.389
Nome #
Type 2 diabetes albuminuric and non-albuminuric phenotypes have different morphological and functional ultrasound features of diabetic kidney disease 283
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 282
Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus 245
Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 207
Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality 202
A Fermented Whole Grain Prevents Lipopolysaccharides-Induced Dysfunction in Human Endothelial Progenitor Cells 195
Circulating Endothelial Cells (EPC) and Endothelium-derived Microparticles (EdMPs) time-course throughout the natural history of type 2 diabetes 194
Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Reply to Rigalleau V, Blanco L, Alexandre L et al [letter] 186
Insulin discovery: A pivotal point in medical history 181
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus 180
SIRT1 rs7896005 polymorphism may be related to coronary artery disease in Caucasians with type 2 diabetes, without affecting all-cause mortality. 170
On the non-linear association between serum uric acid levels and all-cause mortality rate in patients with type 2 diabetes mellitus 167
Influence of severe obesity on circulating endothelial progenitor cells levels and effects of bariatric surgery 165
Probiotic Lisosan G preserves functional properties of human endo- thelial progenitor cells exposed to lipopolysaccharides 157
Association between a metabolic syndrome severity score and all- cause mortality in type 1 diabetes: a 10-year follow-up study 157
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study 151
Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study 148
De-intensification of basal-bolus insulin regimen after initiation of a GLP-1 RA improves glycaemic control and promotes weight loss in subjects with type 2 diabetes 131
Insulin resistance and risk of major vascular events and all-cause mortality in type 1 diabetes: A 10-year follow-up study. diabetes care 2020;43:E139–e141 129
Heterogeneity of chronic kidney disease (CKD) phenothypes in patients with type 1 diabetes mellitus 128
Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies 128
Influence of HDL cholesterol levels on endothelial progenitor cells function in patients with type 2 diabetes mellitus 125
All-cause mortality prediction models in type 2 diabetes: applicability in the early stage of disease 125
SIRT1 rs7896005 polymorphism affects major vascular outcomes, not all-cause mortality, in Caucasians with type 2 diabetes: A 13-year observational study 122
Estimation of Mortality Risk in Type 2 Diabetic Patients (ENFORCE): An Inexpensive and Parsimonious Prediction Model 120
The current landscape for diabetes treatment: Preventing diabetes-associated CV risk 117
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 114
Effects of pioglitazone versus glyburide on endothelial function in type 2 diabetic patients with vascular complications: the SPLENDOR Study 114
The synergic association of hs-CRP and serum amyloid P component in predicting all-cause mortality in patients with type 2 diabetes 110
The rs12917707 polymorphism at the UMOD locus and glomerular filtration rate in individuals with type 2 diabetes: Evidence of heterogeneity across two different European populations 109
null 102
Clinical worthlessness of genetic prediction of common forms of diabetes mellitus and related chronic complications: A position statement of the Italian Society of Diabetology 102
Association between age at diagnosis and all-cause mortality in type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian Multicenter Study 101
null 100
Body mass index versus surrogate measures of central adiposity as independent predictors of mortality in type 2 diabetes 97
Eterogeneità di malattia renale cronica (CKD) nel diabete mellito tipo 1 (DMT1) 97
Relationship between degree of risk factor control and all-cause mortality in individuals with type 2 diabetes: A prospective cohort study 87
Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus 87
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes 87
Risk of all-cause mortality according to the European Society of Cardiology risk categories in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 85
Independent association of history of diabetic foot with all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 83
Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes 77
Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury 66
Prognostic impact of switching to the 2021 chronic kidney disease epidemiology collaboration creatinine-based equation in Caucasian patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular events (RIACE) Italian Multicenter Study 62
null 61
Empagliflozin in adults hospitalised with COVID-19: a (null) hypothesis for RECOVERY 58
Sex differences in food choices, adherence to dietary recommendations and plasma lipid profile in type 2 diabetes – The TOSCA.IT study 50
null 46
null 44
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data 17
null 13
Totale 6.364
Categoria #
all - tutte 18.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202143 0 0 0 0 0 0 0 0 0 0 10 33
2021/2022319 8 17 5 18 67 41 5 16 16 8 18 100
2022/2023623 61 85 40 53 72 72 24 65 107 2 39 3
2023/2024493 33 50 70 25 74 67 28 5 7 18 44 72
2024/20251.637 9 42 38 79 130 199 195 95 161 184 156 349
2025/20262.202 155 253 508 207 230 126 301 80 138 163 41 0
Totale 6.364